At the American Academy of Ophthalmology (AAO) 2025 in Orlando, Dr. Emilio A. Torres-Netto, MD, PhD, FEBO, FWCRS contributed to the instruction course, “What’s New in the Surgical Treatment of Keratoconus”. The advanced program reviewed current surgical algorithms for visual rehabilitation in keratoconus with emphasis on evidence-based patient selection and outcomes.

The faculty panel, led by Senior Instructor Uri Soiberman, MD, included Soosan Jacob, MBBS, FRCS; Leonardo Torquetti, MD; Emilio A. Torres-Netto, MD, PhD, FEBO; and Jimmy Y. Hu, MD. Using a case-based format, the session examined indications and results for corneal implants, corneal cross-linking (CXL) combined with refractive procedures, and deep anterior lamellar keratoplasty in moderate to severe disease.

Dr. Torres-Netto discussed advances in CXL and personalized rehabilitation strategies, including ELZA-PACE CXL as a second-generation, topography-guided approach designed to enhance biomechanical efficacy while preserving epithelial integrity in selected zones. These developments aim to expand treatment eligibility and optimize visual quality in progressive ectasia.

AAO 2025 Event details

  • Meeting: AAO 2025, Orlando, USA
  • Session: What’s New in the Surgical Treatment of Keratoconus
  • Format: In person and on demand; Education Level: Advanced; Topic: Cornea, External Disease
  • Time and location: Saturday, 2:00–3:15 PM EDT; Room W209AB
  • CME: 1 credit
  • Disclosures (as listed by AAO): Uri Soiberman, MD: Mass Eye and Ear: L; Soosan Jacob, MBBS, FRCS: Beauty of Sight: C; LWVI: C; Madhu Instruments Pvt., Ltd.: P; Ziemer Ophthalmics AG: C; Leonardo Torquetti, MD: None; Emilio A. Torres-Netto, MD, PhD, FEBO: None; Jimmy Y. Hu, MD: None.